Total Payments
$18,824
2024 Payments
$6,875
Companies
10
Transactions
35
Payment Breakdown by Category
Consulting$13,819 (73.4%)
Travel$2,524 (13.4%)
Other$1,275 (6.8%)
Food & Beverage$1,119 (5.9%)
Education$87.73 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $13,819 | 6 | 73.4% |
| Travel and Lodging | $2,524 | 7 | 13.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,275 | 1 | 6.8% |
| Food and Beverage | $1,119 | 17 | 5.9% |
| Education | $87.73 | 4 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $9,079 | 10 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $2,760 | 5 | $0 (2024) |
| PFIZER INC. | $2,714 | 4 | $0 (2024) |
| CATALYST PHARMACEUTICALS, INC. | $2,650 | 6 | $0 (2024) |
| Novartis Pharma AG | $762.56 | 2 | $0 (2017) |
| Biogen, Inc. | $564.49 | 2 | $0 (2019) |
| Novo Nordisk Inc | $139.49 | 3 | $0 (2019) |
| BioMarin Pharmaceutical Inc. | $105.54 | 1 | $0 (2022) |
| Ascendis Pharma Inc | $36.10 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $13.50 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,875 | 13 | PFIZER INC. ($2,714) |
| 2023 | $1,285 | 3 | Alexion Pharmaceuticals, Inc. ($1,285) |
| 2022 | $105.54 | 1 | BioMarin Pharmaceutical Inc. ($105.54) |
| 2019 | $629.03 | 4 | Biogen, Inc. ($564.49) |
| 2018 | $9,167 | 12 | GENZYME CORPORATION ($9,079) |
| 2017 | $762.56 | 2 | Novartis Pharma AG ($762.56) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | GENOTROPIN (Drug) | Travel and Lodging | In-kind items and services | $539.81 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 12/13/2024 | PFIZER INC. | GENOTROPIN (Drug) | Travel and Lodging | In-kind items and services | $509.00 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 12/13/2024 | PFIZER INC. | GENOTROPIN (Drug) | Travel and Lodging | In-kind items and services | $390.24 | General |
| Category: ENDOCRINE DISEASE | ||||||
| 09/12/2024 | PFIZER INC. | NGENLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,275.00 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 07/25/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Food and Beverage | In-kind items and services | $36.10 | General |
| Category: Endocrinology | ||||||
| 07/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| Category: Rare Disease | ||||||
| 05/03/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $125.10 | General |
| Category: Rare Disease | ||||||
| 05/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| 05/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Food and Beverage | Cash or cash equivalent | $93.80 | General |
| 05/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Travel and Lodging | Cash or cash equivalent | $59.98 | General |
| 05/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Food and Beverage | Cash or cash equivalent | $28.93 | General |
| 05/02/2024 | CATALYST PHARMACEUTICALS, INC. | — | Food and Beverage | Cash or cash equivalent | $17.14 | General |
| 05/01/2024 | CATALYST PHARMACEUTICALS, INC. | — | Food and Beverage | Cash or cash equivalent | $49.78 | General |
| 10/31/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| Category: Rare Disease | ||||||
| 09/27/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $76.99 | General |
| Category: Rare Disease | ||||||
| 06/15/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $82.75 | General |
| Category: Rare Disease | ||||||
| 07/26/2022 | BioMarin Pharmaceutical Inc. | Vimizim (Biological) | Food and Beverage | In-kind items and services | $105.54 | General |
| Category: MPS IVA | ||||||
| 09/13/2019 | Biogen, Inc. | — | Consulting Fee | Cash or cash equivalent | $554.80 | General |
| 08/07/2019 | Novo Nordisk Inc | Victoza (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 07/24/2019 | Biogen, Inc. | — | Education | In-kind items and services | $9.69 | General |
| 01/29/2019 | Novo Nordisk Inc | — | Education | In-kind items and services | $32.27 | General |
| 10/18/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Consulting Fee | Cash or cash equivalent | $7,680.00 | General |
| 10/18/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $440.00 | General |
| 10/18/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $300.00 | General |
| 10/18/2018 | GENZYME CORPORATION | NO PRODUCT DISCUSSED (Drug) | Travel and Lodging | In-kind items and services | $284.98 | General |
About Sasigarn Bowden
Sasigarn Bowden is a Pediatric Endocrinology healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013915420.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sasigarn Bowden has received a total of $18,824 in payments from pharmaceutical and medical device companies, with $6,875 received in 2024. These payments were reported across 35 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($13,819).
Ad
Practice Information
- Specialty Pediatric Endocrinology
- Location Columbus, OH
- Active Since 07/09/2005
- Last Updated 06/07/2023
- Taxonomy Code 2080P0205X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013915420
Products in Payments
- NO PRODUCT DISCUSSED (Drug) $9,092
- STRENSIQ (Biological) $2,760
- GENOTROPIN (Drug) $1,439
- NGENLA (Drug) $1,275
- ZOL446H (Drug) $762.56
- Vimizim (Biological) $105.54
- Skytrofa (Drug) $36.10
- Victoza (Drug) $32.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Endocrinology Doctors in Columbus
Jennifer Dyer, Md, MD
Pediatric Endocrinology — Payments: $87,357
Pediatric Endocrinology $87,357
William Zipf, Md, MD
Pediatric Endocrinology — Payments: $16,815
Pediatric Endocrinology $16,815
Rolando Lozano, Md, MD
Pediatric Endocrinology — Payments: $14,231
Pediatric Endocrinology $14,231
Leena Nahata, Md, MD
Pediatric Endocrinology — Payments: $3,170
Pediatric Endocrinology $3,170
Robert Hoffman, Md, MD
Pediatric Endocrinology — Payments: $1,151
Pediatric Endocrinology $1,151
Dana Hardin, Md, MD
Pediatric Endocrinology — Payments: $1,119
Pediatric Endocrinology $1,119